Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 37, 2013 - Issue 6
93
Views
2
CrossRef citations to date
0
Altmetric
Short Communication

Utility and Importance of Accurate Hb A2 Measurements for Defining a Strategy for β-Thalassemia Screening: Experience in the Balearic Islands, Spain

, , , , &
Pages 593-598 | Received 28 Jan 2013, Accepted 12 Apr 2013, Published online: 19 Aug 2013

REFERENCES

  • Giambona A, Passarello C, Renda D, Maggio A. The significance of the Hemoglobin A(2) value in screening for hemoglobinopathies. Clin Biochem. 2009;42(18):1786–1796.
  • Dell’Edera D, Pacella E, Epifania AA, et al. Importance of molecular biology in the characterization of β-thalassemia carriers. Eur Rev Med Pharmacol Sci. 2011;15(1):79–86.
  • Sabath DE, Greisman HA. A multiplex approach to the molecular diagnosis of β-thalassemia. J Mol Diagn. 2011;13(4):369–370.
  • Sivalingam M, Looi ML, Zakaria SZ, et al. Molecular study and genotype/phenotype correlation of β-thalassaemia in Malaysia. Int J Lab Hematol. 2012;34(4):377–382.
  • Weatherall DJ, Clegg JB. The Thalassaemia Syndromes, 3rd ed. Oxford: Blackwell Scientific, 1981.
  • Kutlar A, Kutlar F, Gu L-G, Mayson SM, Huisman THJ. Fetal hemoglobin in normal adults and β-thalassemia heterozygotes. Hum Genet. 1990;85(1):106–110.
  • Rund D, Filon D, Strauss N, Rachmilewitz EA, Oppenheim A. Mean corpuscular volume of heterozygotes for β-thalassemia correlates with the severity of mutations. Blood. 1992;79(1):238–243.
  • Stefanis L, Kanavakis E, Traeger-Synodinos J, Tzetis M, Metaxotou-Mavromati A, Kattamis C. Hematologic phenotype of the mutations IVS1-n6 (T→C), IVS1-n110 (G→A), and CD39 (C→T) in carriers of β-thalassemia in Greece. Pediatr Hematol Oncol. 1994;11(5):509–517.
  • Bragós IM, Noguera NI, Raviola MA, Milani C. Genética molecular de β talasémicos heterocigotos. Inter-relación con parámetros hematológicos. Rev Cubana Hematol Inmunol Hemoter.2005;21(1):1–11.
  • Mamtani M, Jawahirani A, Rughwani V, das K, Kulkarni H. Value of mean corpuscular volume and mean corpuscular haemoglobin in screening of β-thalassemia trait. Acta Haematol. 2006;116(3):223–225.
  • Khattak SA, Ahmed S, Anwar J, Ali N, Shaikh KH. Prevalence of various mutations in β thalassaemia and its association with haematological parameters. J Pak Med Assoc. 2012;62(1):40–43.
  • Atanasovska B, Bozhinovski G, Chakalova L, Kocheva S, Karanfilski O, Plaseska-Karanfilska D. Molecular diagnostics of β-thalassemia. BJMG. 2012;15(Suppl):61–65.
  • Old JM. Screening and genetic diagnosis of haemoglobinopathies. Scand J Clin Lab Invest. 2007;67(1):71–86.
  • López-Escribano H, Parera M, Guix P, et al. Balearic archipelago: three islands, three β-thalassemia population patterns. Clin Genet. 2013;83(2):175–180.
  • Moreno I, Bolufer P, Perez ML, Barragán E, Sanz MA. Rapid detection of the major Mediterranean β-thalassaemia mutations by real-time polymerase chain reaction using fluorophore-labelled hybridization probes. Br J Haematol. 2002;119(2):554–557.
  • Clark BE, Thein SL. Molecular diagnosis of haemoglobin disorders. Clin Lab Haematol. 2004;26(3):159–176.
  • Vrettou C, Kanavakis E, Traeger-Synodinos J, et al. Molecular studies of β-thalassemia heterozygotes with raised Hb F levels. Hemoglobin. 2000;24(3):203–220.
  • Mosca A, Paleari R, Ivaldi G, Galanello R, Giordano PC. The role of Haemoglobin A(2) testing in the diagnosis of thalassaemias and haemoglobinopathies. J Clin Pathol 2009;62(1):13–17.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.